Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of inhibiting human immunodeficiency virus type 1 (HIV-1) infection through the administration of CCR5 chemokine receptor antagonists

Methods of inhibiting human immunodeficiency virus type 1 (HIV-1) infection through the administration of CCR5 chemokine receptor antagonists

US Patent 7858298 · Granted Dec 28, 2010

Estimated economic value: $2,220,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-MSR1 antibodies and methods of use thereof2025
Anti-TMPRSS6 antibodies and uses thereof2025
Steroids and protein-conjugates thereof2025
Bis-octahydrophenanthrene carboxamides and protein conjugates thereof2025
Therapeutic uses of anti-GITR antibodies2025
Antibody-drug conjugates comprising GLP1 peptidomimetics and uses thereof2025
Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments2025
Bis-octahydrophenanthrene carboxamide derivatives and protein conjugates thereof2025
Human antibodies to ebola virus glycoprotein2024
Tubulysins and protein-tubulysin conjugates2024
Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use ther2024
VEGF traps and mini-traps and methods for treating ocular disorders and cancer2024